| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |